or Try an Advanced Search...

    Nontuberculous Mycobacteria Stocks List

    Symbol Grade Name % Change
    XAIR C Beyond Air, Inc. -14.00
    INSM D Insmed, Inc. 1.55
    ANTX D AN2 Therapeutics, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Conglomerates
    Related Stock Lists: Bacteriology Biopharmaceutical Tuberculosis Bacterial Disease Infectious Diseases Lung Infection Lung Infections Microbiology Mycobacterium Coronavirus Cystic Fibrosis Hypertension Lower Respiratory Tract Infection Lung Diseases Medicine Pseudomonas Pulmonary Hypertension Respiratory And Other Diseases Respiratory Tract Respiratory Tract Infection

    Related ETFs - A few ETFs which own one or more of the above listed Nontuberculous Mycobacteria stocks.

    Symbol Grade Name Weight
    BKIV A BNY Mellon Innovators ETF 4.12
    FCUS B Pinnacle Focused Opportunities ETF 4.05
    PTH D Invesco DWA Healthcare Momentum ETF 3.94
    XBI B SPDR S&P Biotech ETF 2.49
    HELX D Franklin Genomic Advancements ETF 2.11
    View all Nontuberculous Mycobacteria ETFs...
    Compare ETFs
    Compare BKIV to PTH Compare PTH to HELX Compare PTH to XBI

        Nontuberculous Mycobacteria Stocks Recent News

        Date Stock Title
        Nov 1 INSM Do You Believe in the Growth Potential of Insmed (INSM)?
        Nov 1 INSM Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates
        Nov 1 INSM Insmed Third Quarter 2024 Earnings: EPS Misses Expectations
        Nov 1 INSM Insmed Inc (INSM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
        Nov 1 INSM Q3 2024 Insmed Inc Earnings Call
        Oct 31 INSM Insmed Incorporated (INSM) Q3 2024 Earnings Call Transcript
        Oct 31 INSM Insmed (INSM) Reports Q3 Earnings: What Key Metrics Have to Say
        Oct 31 INSM Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates
        Oct 31 INSM Insmed: Q3 Earnings Snapshot
        Oct 31 INSM Insmed GAAP EPS of -$1.27 misses by $0.06, revenue of $93.43M beats by $0.26M
        Oct 31 INSM Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update
        Oct 30 INSM Insmed Q3 2024 Earnings Preview
        Oct 30 INSM Insmed (INSM) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
        Oct 29 INSM How to play biotech stocks: Insmed and Wave Life Sciences
        Oct 29 XAIR Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast
        Related Industries: Biotechnology Conglomerates
        Related Stock Lists: Bacteriology Biopharmaceutical Tuberculosis Bacterial Disease Infectious Diseases Lung Infection Lung Infections Microbiology Mycobacterium Coronavirus Cystic Fibrosis Hypertension Lower Respiratory Tract Infection Lung Diseases Medicine Pseudomonas Pulmonary Hypertension Respiratory And Other Diseases Respiratory Tract Respiratory Tract Infection
        Nontuberculous Mycobacteria

        Nontuberculous mycobacteria (NTM) are a group of bacteria that are related to the bacteria that cause tuberculosis (TB). NTM are found in the environment, including soil and water, and can cause infections in humans. NTM infections are usually mild and can be treated with antibiotics, but some can be more serious and difficult to treat.

        Browse All Tags